1368-Industry news-CACLP-The largest IVD Expo & Conference

22 results for “non-small-cell lung cancer” in Newsroom

Sort by date

Industry news | 21 July, 2021
Agilent Technologies Obtains CE Mark for Expanded Use of PD-L1 CDx in NSCLC

Agilent Technologies on Tuesday announced that it has received CE marking for the expanded use of its PD-L1 IHC 22C3 pharmDx companion diagnostic assay in patients with non-small cell lung cancer.
Industry news | 30 July, 2019
Biodesix Looks to Become ‘the’ Lung Cancer Detection Co.

Biodesix isn’t looking to just be another company with lung cancer detection tests. It wants to be the lung cancer detection company. And with its most recent acquisition, the Boulder, CO-just might achieve that goal.

of 3

Content types Reset

✔ All (22)

✔ Press release (0)

✔ Industry news (22)

Opening Countdown

0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Visitor registration Book your stand

CACLP - The largest IVD Expo & Conference

Room 1808, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Visit Exhibit Conferences Webinars Newsroom About Us FAQs

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

No, thanks. Yes, I agree.

Subscribe to CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.

Name *
Email *
Telephone
Job title
Company name *
Country *

By submitting the form here, you agree to our Privacy Policy and agree that we may store and access the information you provide.

Thank you for subscribing to CACLP News!

To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.

Go back

22 results for “non-small-cell lung cancer” in Newsroom

Agilent Technologies Obtains CE Mark for Expanded Use of PD-L1 CDx in NSCLC

Biodesix Looks to Become ‘the’ Lung Cancer Detection Co.

Stay in touch with CACLP News

Subscribe to CACLP News

Thank you for subscribing to CACLP News!